How RealTime-Devana Helped Accellacare’s Integrated Site Network

Accellacare_logo1

BEFORE

Accellacare Before RealTime

AFTER

Accellacare After RealTime

Overview

Accellacare delivers clinical trial services to pharmaceutical, biotechnology, and medical device industries. Accellacare extends across the globe with 112 active research sites in eight countries with expertise in a wide range of therapeutic areas. It has relationships with 275 Principal Investigators and connects to 8.5 million+ patients.

The Challenge

A highly respected and top-performing site organization was challenged by the inability to accurately measure turnaround times without cumbersome spreadsheets. This was made particularly complex given its 14 locations and 54 investigative sites, spread across the mid-Atlantic region of the U.S.

The additional goal of drastically reducing study start-up timelines was also put into place by the leadership team.

The Solution

After finding a solution that met the scope of their needs and could scale as they grew, the Accellacare leadership team committed to adopting RealTime-Devana, previously PROPEL, organization-wide.

The Results

Within six months, the sponsor/CRO feasibility request turnaround time average was reduced from six days to four days. Further, sponsor/CRO contract received to fully-executed time was cut from an average of 90 days to just 22 days, a 76% reduction in time.

With RealTime-Devana, Accellacare was able to accelerate clinical trial processes across their organization. Other benefits include:

  • Real-time performance metrics and reporting
  • Common platform for central and site-based teams
  • Exponential growth and scalability become a reality
  • Single source of truth
  • Centralized communications and trial management

Ready to explore the leader in clinical site technology? We’d love to connect. Complete the form to learn how RealTime-Devana can work for you.

Request a Live Demo